Order results by:
| Issue | Title | |
| Vol 7, No 5 (2011) | ARRESTING OF COMPLICATED HYPERTENSIVE CRISES IN THE PHYSICIAN’S PRACTICE: URAPIDIL VALUE AND STUDY RESULTS | Abstract similar documents |
| G. P. Arutyunov, L. G. Oganezova | ||
| "... to re-infused urapidil 12.5 mg) or enalaprilat (the initial dose 1.25 mg). The frequency of target blood ..." | ||
| Vol 9, No 4 (2013) | URAPIDIL: MODERN MEDICINE FOR THE TREATMENT OF HYPERTENSIVE CRISES | Abstract similar documents |
| A. V. Melekhov, Yu. I. Ostrovskaya | ||
| "... Aim. To study the antihypertensive efficacy of urapidil, as well as to determine the optimal ..." | ||
| Vol 10, No 5 (2014) | USE OF URAPIDIL - ANTIHYPERTENSIVE DRUG WITH DOUBLE ACTION - NEW DIRECTION IN TREATMENT OF HYPERTENSIVE CRISES | Abstract similar documents |
| V. R. Abdrakhmanov, N. I. Gaponova, N. F. Plavunov | ||
| "... Results of clinical trials devoted to urapidil, antihypertensive drug having central ..." | ||
| Vol 8, No 5 (2012) | URAPIDIL IN THE TREATMENT OF MEDICAL EMERGENCIES CAUSED BY BLOOD PRESSURE INCREASE | Abstract similar documents |
| N. I. Gaponova, V. R. Abdrakhmanov, S. N. Tereschenko | ||
| "... Results of experimental and clinical studies devoted to urapidil combining central ..." | ||
| Vol 7, No 4 (2011) | ON THE 125TH ANNIVERSARY OF ACETYLSALICYLIC ACID | Abstract similar documents |
| I. N. Bokarev, L. V. Popova | ||
| Vol 2, No 1 (2006) | SUPRAVENTRICULAR RHYTHM DISTURBANCES TREATMENT WITH ANTIARHYTHMIC DRUG III CLASS NIBENTAN IN PATIENTS WITH ISCHEMIC HEART DISEASE (EXPERIMENTAL, CLINICAL AND MORPHOLOGICAL EVIDENCES) | Abstract similar documents |
| I. A. Latfullin, R. F. Gaifullina | ||
| "... infarction (AMI). SRD relief was achieved with 1% solution of nibentan in dose of 0.125 mg/kg patient ..." | ||
| Vol 18, No 6 (2022) | Relationship of the White Coat Effect with Endpoints and Several Prognostic Indicators in Hypertensive Patients Treated with Regular Antihypertensive Therapy | Abstract similar documents |
| G. F. Andreeva, M. I. Smirnova, V. M. Gorbunov, A. S. Kurekhyan, Y. N. Koshelyaevskaya | ||
| "... . Material and Methods. We analyzed the data of a prospective cohort study, which included 125 patients ..." | ||
| Vol 5, No 3 (2009) | COMPARATIVE CONTROLLED STUDY OF ANTIHYPERTENSIVE EFFICACY AND SAFETY OF CARVEDILOL IN PATIENTS WITH HYPERTENSION AND OBESITY OR DIABETES 2 TYPE (BASED ON RESULTS OF MULTICENTER TRIAL ACCORD) | Abstract similar documents |
| Yu. V. Yu.V. Lukina, S. Yu. Martsevich, A. D. Deev, S. A. Shalnova | ||
| "... to current therapy in dose of 6,25 mg BID, in 2 weeks the dose was increased to 12,5 mg BID ..." | ||
| Vol 14, No 1 (2018) | MODERN POSSIBILITIES OF ACHIEVING TARGET BLOOD PRESSURE LEVEL IN HYPERTENSIVE PATIENTS IN OUTPATIENT PRACTICE: THE LEADER STUDY RESULTS | Abstract similar documents |
| D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, O. M. Drapkina, S. A. Boytsov | ||
| "... /50, 10/50, 5/100, 10/100 mg) or hydrochlorothiazide/losartan (12.5/50, 12.5/100, 25/100 mg ..." | ||
| Vol 2, No 1 (2006) | INFLUENCE OF ANTIHYPERTENSIVE THERAPY ON PSYCHOLOGICAL STATUS OF CHERNOBYL NUCLEAR POWER PLANT ACCIDENT CONSEQUENCES LIQUIDATORS | Abstract similar documents |
| E. M. Manoshkina, I. I. Razdobreeva, S. K. Kukushkin | ||
| "... ), hypothiazide was added if necessary (12.5-25 mg daily) and afterwards – atenolol (12.5-100 mg daily). In CG AHT ..." | ||
| Vol 8, No 1 (2012) | THE COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL VALSARTAN AS A MONOTHERAPY OR IN COMBINATION WITH HYDROCHLOROTHIAZIDE AND BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREE AND METABOLIC SYNDROME | Abstract similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, V. P. Voronina, L. Yu. Drozdova | ||
| "... mm Hg) was not reached, a fixed combination of valsartan with hydrochlorothiazide (80/12.5 mg ..." | ||
| Vol 5, No 1 (2009) | COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Velishanina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P. Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiseleva, S Yu. Levashov, V. A. Nevsorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnyukova, V. V. Yakusevich, E. N. Akulina, V. A. Budanova, T. S. Bondarenko, V. P. Voronina, I. N. Gozhaja, I. I. Igricenco, A. V. Drogan, N. A. Dmitrieva, F. M. Dyshekova, A. I. Zaiceva, A. N. Ikovnikova, G. A. Ilicheva, I. S. Irhina, L. A. Kovaleva, O. N. Kutkina, E. A. Kudrjashev, A. Z. Leonidova, E. N. Loginova, M. P. Marganjan, O. V. Nastradin, A. N. Nikitina, I. N. Nikolskaja, I. E. Pashinceva, A. S. Petrochenko, O. M. Pasnenkova, E. S. Potapova, A. A. Serazhim, M. N. Sergeev, V. V. Sidorenko, V. A. Simonov, D. V. Sirotenko, I. N. Spanderashvili, A. N. Strunina, E. S. Timoschenko, S. N. Tolpygina, M. R. Redkina | ||
| "... received C 12,5 mg BID (Vedicardol, “Sintez”), another part – M 25 mg/day BID. Doubling dose of β-blockers ..." | ||
| Vol 5, No 2 (2009) | EFFICACY AND SAFETY OF FIXED COMBINATION OF LISINOPRIL AND HYDROCHLOROTHIAZIDE FOR MANAGEMENT OF VASCULAR DISORDERS IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| L. A. Haisheva | ||
| "... combination of lisinopril (5мг) and hydrochlorothiazide (12,5 mg). Patients of the 2nd group were treated ..." | ||
| Vol 16, No 2 (2020) | The Effects of Telmisartan and Its Combinations on Office Blood Pressure: Results of Prospective Observational Study TAINA | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, F. T. Ageev, G. S. Anikin, E. Kh. Akhmetzyanova, E. I. Bezuglova, A. B. Bekoeva, N. Yu. Borovkova, N. G. Vinogradova, E. V. Gorbunova, A. A. Goryacheva, E. S. Zhugrova, O. A. Kislyak, S. M. Klyashev, V. P. Kuzmin, A. A. Lipchenko, G. V. Matyushin, E. A. Mikhailova, V. A. Nevzorova, A. G. Obrezan, T. A. Petrichko, M. M. Petrova, A. N. Reider, A. N. Repin, V. I. Sadovoy, N. P. Sanina, A. E. Skripchenko, R. I. Stryuk, I. V. Faiyance, L. A. Khaisheva, N. R. Khasanov, R. A. Khokhlov, E. E. Tsareva, A. L. Cherkashina, I. I. Shaposhnik, I. A. Shelestova, R. N. Shepel, E. V. Shikh, D. A. Yakhontov | ||
| "... .4±12.1/80.8±7.3 mm Hg at the end of the 4th week and to 125.3±7.6/78.2±6.1 mm Hg – at the end of the 12 ..." | ||
| Vol 5, No 6 (2009) | ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN HYPERTENSIVE PATIENTS WITH AMLODIDINE: ORIGINAL DRUG VERSUS GENERIC | Abstract similar documents |
| S. Yu. Martsevich, N. A. Dmitrieva, A. D. Deev, L. A. Sokolova, V. V. Jakusevich, J. V. Lukina, M. A. Maximova, A. V. Zaharova, A. A. Serazhim, V. P. Voronina | ||
| "... amlodipine, respectively, when they were combined with lisinopril (10 mg OD) and hydrochlorothiazide (12,5 mg ..." | ||
| Vol 6, No 2 (2010) | COMPARISON OF ENALAPRIL AND PERINDOPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND LEFT VENTRICLE SYSTOLIC DYSFUNCTION | Abstract similar documents |
| Yu. I. Grinshtein, O. L. Barbarash, D. A. Yakhontov, A. E. Popelysheva, V. V. Shabalin, N. B. Osetrova | ||
| "... ) or with perindopril 4-8 mg OD (n=26). Hydrochlorothiazide (12,5-25 mg OD) was added in case of ineffective therapy ..." | ||
| Vol 7, No 5 (2011) | EFFECT OF ERYTHROPOIETIN ON THE CLINICAL COURSE OF CHRONIC HEART FAILURE IN PATIENTS WITH ANEMIA: RESULTS OF NOT COMPARATIVE STUDY | Abstract similar documents |
| V. M. Provotorov, S. A. Avdeeva | ||
| "... increase in hemoglobin (+12.5%; p<0.001) and hematocrit (+5.8%; p<0.001) levels, as well as increase in red ..." | ||
| Vol 7, No 5 (2011) | DYNAMICS OF ACUTE CORONARY SYNDROME PATIENT MANAGEMENT IN NONIVASIVE PRIMARY VASCULAR CENTER (ACCORDING TO RECORD AND RECORD-2 REGISTERS) | Abstract similar documents |
| V. M. Provotorov, I. Shevchenko, R. Islamov | ||
| "... heparin, 12.5% of patients – enoxaparin and 7.4% - fondaparinux. 2.7% of ACS patients were transferred ..." | ||
| Vol 9, No 2 (2013) | COMPARISON OF HEART RATE VARIABILITY ADJUSTED FOR AGE AND HEART RATE IN WOMEN WITH RHEUMATOID ARTHRITIS AND WOMEN WITHOUT RHEUMATIC DISEASES | Abstract similar documents |
| D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. I. Nasonov | ||
| "... diseases (n=125) were included into control group. The presence of traditional cardiovascular risk factors ..." | ||
| Vol 3, No 4 (2007) | RESISTANCE TO ACETYLSALICYLIC ACID AND PREVALENCE OF THROMBOSIS IN PATIENTS WITH STABLE ANGINA | Abstract similar documents |
| N. F. Putchinyan, N. V. Furman, P. Ya. Dovgalevskyi | ||
| "... with stable angina of II-III functional classes received basic therapy included ASA (125 mg daily) to prevent ..." | ||
| Vol 4, No 3 (2008) | OMEGA-3 POLYUNSATURATED FATTY ACIDS IN ATRIAL FIBRILLATION PREVENTION AFTER SURGICAL MYOCARDIAL REVASCULARIZATION | Abstract similar documents |
| A. V. Panov, B. A. Tatarskiy, M. L. Gordeev, R. I. Nilk | ||
| "... . 189 patients (125 men, 64 women; aged 64,2±9,4 y.o.) with IHD having indications to CABG were enrolled ..." | ||
| Vol 17, No 4 (2021) | Association of smoking with indicators of the structure and function of left ventricle of the heart in middle-aged men | Abstract PDF (Eng) similar documents |
| O. Yu. Isaykina, V. B. Rozanov, A. A. Aleksandrov, M. B. Kotova, M. A. Isaykina, O. M. Drapkina | ||
| "... 15. The duration of smoking cessation among former smokers was 14.4 (12.5; 16.2) years. The average ..." | ||
| Vol 17, No 3 (2021) | Chronic Heart Failure in Patients with Arterial Hypertension Associated with Obstructive Sleep Apnea Syndrome: Possible Options to Pathogenetic Therapy | Abstract similar documents |
| A. V. Yakovlev, S. N. Shilov, E. N. Berezikova, N. F. Yakovleva, A. T. Teplyakov, E. V. Grakova, K. V. Kopeva, I. A. Efremov | ||
| "... natriuretic peptide precursor (NT-proBNP) ≥125 pg/ml; 3) LVEF <50%; 4) the duration of hypertension ..." | ||
| Vol 17, No 5 (2021) | Long-term Results of Drug and Interventional Treatment in Patients with Morphologically Verified Idiopathic Arrhythmias | Abstract similar documents |
| O. V. Blagova, A. V. Nedostup, E. A. Kogan | ||
| "... therapy: acyclovir (n=10); immunoglobulin G 10-12.5 g (n=2); hydroxychloroquine 200 mg/day (n=15 ..." | ||
| Vol 18, No 2 (2022) | Comparative Efficacy of Single Pill Combinations of Azilsartan Medoxomil/Chlorthalidone and Losartan/Hydrochlorothiazide in Patients with Hypertension and Heart Failure with Preserved Ejection Fraction | Abstract similar documents |
| Zh. D. Kobalava, A. F. Safarova, Kh. M. Gudieva, M. A. Markova, A. E. Petrosyan | ||
| "... the AZM/CTD 40/12.5 mg/day (group 1; n=28) or LOS/HCT 100/12.5 (group 2; n=28) within 4 weeks. Patients ..." | ||
| Vol 18, No 4 (2022) | Respiratory Muscle Strength in Patients with Coronary Heart Disease and Different Musculoskeletal Disorders | Abstract PDF (Eng) similar documents |
| E. D. Bazdyrev, N. A. Terentyeva, N. A. Galimova, K. E. Krivoshapova, O. L. Barbarash | ||
| "... values, and the strength of the expiratory muscles was 1.25 times lower compared to the inspiratory ..." | ||
| Vol 12, No 2 (2016) | CARDIORENAL INTERACTION IN DECOMPENSATED CHRONIC HEART FAILURE | Abstract similar documents |
| Zh. D. Kobalava, S. V. Villevalde, M. A. Efremovtseva | ||
| "... and persistent, de novo, and on the background of CKD. Results. CKD was detected in 125 (45%) patients. AKI ..." | ||
| Vol 7, No 1 (2011) | THE CHOICE OF THE DRUG AMLODIPINE FOR THE HYPERTENSION TREATMENT FROM THE STANDPOINT OF ECONOMIC FEASIBILITY | Abstract similar documents |
| S. Yu. Martsevich, N. A. Dmitrieva, A. D. Deev, Yu. V. Lukina, L. A. Sokolova, V. V. Yakusevich | ||
| "... and then successively lisinopril 10 mg daily and hydrochlorothiazide 12.5 mg one time per day were added. The total ..." | ||
| Vol 5, No 5 (2009) | EFFICACY AND SAFETY OF VASOACTIVE BETA-BLOCKERS IN ACUTE PHARMACOLOGICAL TEST IN HYPERTENSIVE PATIENTS OF DIFFERENT AGES | Abstract similar documents |
| O. V. Fedorishina, A. A. Dzizinsky, K. V. Protasov, V. A. Protasova, T. I. Kucherova, E. G. Zakharova, D. D. Baskhaeva, T. S. Sukhoroslova, O. V. Perkova | ||
| "... (≥60 y.o.). All patients were randomized for carvedilol (12.5 mg once daily) or nebivolol (5 mg once ..." | ||
| Vol 7, No 2 (2011) | A COMPARATIVE STUDY OF THE EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN MONOTHERAPY OR IN COMBINATION WITH S-AMLODIPINE AND INDAPAMIDE IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 DEGREES. RESULTS OF THE CLINICAL RANDOMIZED CROSSOVER STUDY | Abstract similar documents |
| S. Yu. Martsevich, S. N. Tolpygina, V. P. Voronina, O. V. Lerman, Yu. V. Lukina, N. A. Dmitrieva, I. V. Vashurina | ||
| "... . After 8 weeks of therapy BP reduction was 27.2±12.2/12.0±6.1 mm Hg in group 1 and 29.9±10.5/12.5±7.2 mm ..." | ||
| Vol 6, No 2 (2010) | VALSARTAN IN EVERYDAY CLINICAL PRACTICE IN RUSSIA: ANTIHYPERTENSIVE EFFICACY AND INFLUENCE ON SEXUAL FUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| V. I. Podzolkov, V. A. Bulatov, A. V. Vigdorchik | ||
| "... of the valsartan with hydrochlorothiazide (12,5-25 mg/d), amlodipine (5-10 mg/d) or any other antihypertensive ..." | ||
| Vol 13, No 3 (2017) | INFLUENCE OF PATIENTS’ PREHOSPITAL ATTENDANCE AT OUTPATIENT CLINICS ON LONG-TERM OUTCOMES OF ACUTE CORONARY SYNDROME: LIS-3 STUDY | Abstract similar documents |
| Yu. V. Semenova, N. P. Kutishenko, A. V. Zagrebelnyy, M. L. Ginzburg, A. D. Deev, S. Yu. Martsevich | ||
| "... ). Follow-up period was 14-35 months (88.44% follow-up rate). During-follow-up period 12.5% of patients died ..." | ||
| Vol 7, No 4 (2011) | VALUE OF THERAPEUTIC EQUIVALENCE IN SUBSTITUTION OF ORIGINAL DRUG WITH GENERIC BY EXAMPLE OF FOSINIPRIL | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, Zh. D. Kobalava, E. K. Shavarova | ||
| "... of ineffective BP control (>140/90 mm Hg) hydrochlorothiazide 12.5 mg was added initially and dose fosinopril ..." | ||
| Vol 10, No 2 (2014) | IMPACT OF ATRIAL FIBRILLATION ON THE NEAR AND LONG-TERM PROGNOSIS OF LIFE AFTER ACUTE MYOCARDIAL INFARCTION. THE DATA OF THE LIS-1 STUDY (LYUBERTSY MORTALITY STUDY OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION) | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, M. L. Gynzburg, L. Yu. Drozdova, A. D. Deev, V. P. Smirnov | ||
| "... .025). However, these differences were not statistically significant when adjusted for age and gender (OR=1.25 ..." | ||
| Vol 11, No 2 (2015) | COMPARATIVE EVALUATION OF HEMODYNAMIC CHARACTERISTICS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ARTERIAL HYPERTENSION | Abstract similar documents |
| Y. E. Teregulov, D. K. Husainova, D. I. Abdulganeeva, S. D. Mayanskaya | ||
| "... hyperkinetic type was observed in 22.9% of the cases, eukinetic - in 65.6%, hypokinetic - in 12.5 ..." | ||
| Vol 10, No 1 (2014) | CLINICAL AND MORPHOLOGICAL APPROACH TO DIAGNOSIS OF "IDIOPATHIC" ARRHYTHMIAS AND DILATED CARDIOMYOPATHY SYNDROME AS A BASIS FOR DIFFERENTIATED THERAPY. Part I (Diagnostics) | Abstract similar documents |
| O. V. Blagova, A. V. Nedostup, E. A. Kogan, V. A. Sulimov, Yu. V. Osipova, V. P. Sedov, A. G. Kupriyanova, V. A. Zaydenov, A. E. Donnikov, V. V. Kadochnikova | ||
| "... women, age 46.9±12.5 years) were included in the main group. 51 people (patients with ischemic heart ..." | ||
| Vol 9, No 6 (2013) | EFFECT OF SIMVASTATIN THERAPY ON INDICATORS OF TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE | Abstract similar documents |
| T. V. Pinchuk, Y. N. Fedulaev, G. A. Khairetdinova, A. A. Kozina, V. N. Ryzhenkov, N. M. Ahmedzhanov | ||
| "... =125) with diastolic CHF (relaxation disturbances and pseudonormalization) were included into the open ..." | ||
| Vol 1, No 2 (2005) | ANTIHYPERTENSIVE, ORGAN PROTECTIVE, AND METABOLIC EFFICIENCY OF SPIRAPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| M. V. Leonova, M. A. Demidova, A. V. Tarasov, Y. V. Belousov | ||
| "... after two weeks, and after next 4 weeks hydrochlorothiazide in daily dose 12,5-25 mg could be added ..." | ||
| Vol 1, No 2 (2005) | ESTIMATION OF ANTIHYPERTENSIVE EFFECT EQUABILITY FOR TWO PRESENTATIONS OF NIFEDIPINE WITH DAILY BLOOD PRESSURE MONITORING | Abstract similar documents |
| V. M. Gorbunov, E. V. Alimova, A. D. Deev | ||
| "... and methods. 147 patients with arterial hypertension (age 53,8±12,5 years) were included into multicenter ..." | ||
| Vol 3, No 3 (2007) | TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION 1-2 GRADE WITH METOPROLOL TARTRATE AND ANALYSIS OF HEART RATE VARIABILITY | Abstract similar documents |
| V. E. Oleinikov, V. A. Budanova, A. V. Kulyutsin | ||
| "... pressure (BP) wasn’t reached, hydrochlorothiazide (12,5-25 mgdaily) was added. Ambulatory BP and ECG ..." | ||
| Vol 5, No 1 (2009) | EFFECT OF MORNING AND EVENING RAMIPRIL TAKING ON AMBULATORY BLOOD PRESSURE PROFILE IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| V. M. Gorbunov, E. J. Fedorova, A. D. Deev, E. V. Platonova, O. J. Isaikina | ||
| "... ,7±1,2/11,5±1,3% to 12,5±1,2/19,1±1,3 % (p<0,01). Morning taking did not have significant influence ..." | ||
| Vol 5, No 1 (2009) | SAFARI - RANDOMISED TRIAL ON COMPLEX THERAPY OF ARTERIAL HYPERTENSION AND DISLIPIDEMY. THE MAIN RESULTS | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, V. V. Yakusevich, A. D. Deev, A. A. Serazhim, T. V. Bobkova, L. P. Volkonskaya, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, J. V. Lukina, M. A. Maksimova, A. A. Serazhim, S. N. Tolpygina, E. V. Shilova | ||
| "... 12,5 mg/day OD and bisiprolol 5 mg OD was added if antihypertensive effect was insufficient ..." | ||
| Vol 14, No 2 (2018) | IMPACT OF LEVOSIMENDAN ON RENAL FUNCTION IN COMPLEX TREATMENT OF ACUTE DECOMPENSATED HEART FAILURE | Abstract similar documents |
| M. V. Lediakhova, S. N. Nasonova, I. V. Zhirov, M. V. Andreevskaya, R. M. Bogieva, T. M. Uskach, M. A. Saidova, V. P. Masenko, S. N. Tereshchenko | ||
| "... pressure >125 mmHg. All patients were randomized into 2 groups of 15 people each. In the first group ..." | ||
| Vol 14, No 2 (2018) | THE ANALYSIS OF DIFFERENCES IN DOCTORS PREFERENCES IN THE PRESCRIPTIONS OF ANTIHYPERTENSIVE DRUGS IN FOUR REGIONS OF THE FAR EASTERN FEDERAL DISTRICT | Abstract similar documents |
| M. S. Soboleva, Е. E. Loskutova | ||
| "... %) and spironolactone (from 3% to 12.5%), and in group of angiotensin II antagonists – losartan (from 0.4% to 15 ..." | ||
| Vol 2, No 2 (2006) | CLINICAL EFFICACY AND PECULIARITY OF COMPLIANCE WITH 48-WEEK LONG THERAPY WITH EGILOK RETARD IN PATIENTS WITH MILD TO MODERATE HYPERTENSION | Abstract similar documents |
| V. E. Oleynikov, V. A. Budanova, A. V. Kulucin | ||
| "... daily on 2 or 8 week, and on 12-16 weeks hydrochlorothiazide 12,5-25 mg daily and then nifedipine 20 mg ..." | ||
| Vol 2, No 3 (2006) | ORGANOPROTECTIVE EFFECTS OF BENASEPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| V. S. Zadionchenko, T. V. Adasheva, A. M. Shamshinova, I. Y. Malishev, E. B. Manukhina, A. Y. Bogolyubskaya, K. M. Golovanov, M. A. Arakelyan, O. L. Silakova | ||
| "... patients were prescribed benasepril 5-10 mg daily. If necessary, hydrochlorothiazide 12,5 mg daily ..." | ||
| Vol 4, No 1 (2008) | VASCULAR REMODELING AND HEART RATE VARIABILITY IN DIFFERENT ANTIHYPERTENSIVE THERAPIES | Abstract similar documents |
| E. D. Golovanova | ||
| "... and perindopril (Noliprel Forte, 1 tab/d: perindopril 4 mg and indapamide 1,25 mg) on pulse wave velocity (PWV ..." | ||
| Vol 4, No 3 (2008) | ESTIMATION OF CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC CARVEDILOLS IN PATIENTS WITH HYPERTENSION OF 1-2 GRADES | Abstract similar documents |
| E. I. Bambysheva, S. N. Tolpygina, D. F. Guranda, I. E. Koltunov, V. G. Belolipetskaja, S. J. Martsevich | ||
| "... carvedilols (12,5 mg twice a day) were prescribed to the patients. Hydrochlorothiazide was added followed ..." | ||
| Vol 4, No 4 (2008) | INFLUENCE OF ABDOMINAL OBESITY ON HEART STRUCTURAL AND FUNCTIONAL CHANGES AND POSSIBILITY OF THEIR PHARMACOLOGICAL CORRECTION IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| V. R. Veber, M. P. Rubanova, M. N. Kopina, S. V. Zhmajlova, D. P. Shmatko, I. V. Prozorova | ||
| "... .o.) with HT and AO were included in the first group. 127 women (aged 50,05±1,7 y.o.) and 125 men (aged 49,61±1 ..." | ||
| Vol 16, No 2 (2020) | Drug Correction of Vascular Remodeling in Patients with Hypertension: Results of 52-Week Prospective Study ARTERIA-AG | Abstract similar documents |
| O. V. Fedorishina, K. V. Protasov, A. M. Torunova | ||
| "... ; from 169.5 (160;190)/103.5 (95;109) to 135.0 (125;141)/83.0 (77;88) mm Hg and from 139.9 (136;152)/86 ..." | ||
| Vol 16, No 6 (2020) | Patients with Atrial Fibrillation in Clinical Practice: Comorbidity, Drug Treatment and Outcomes (Data from RECVASA Registries) | Abstract similar documents |
| M. M. Loukianov, E. Yu. Andreenko, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, E. Yu. Okshina, V. V. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, V. G. Klyashtorny, E. V. Kudryashov, Ju. E. Tatsii, S. A. Boytsov, O. M. Drapkina | ||
| "... .7%, in Kursk - 12.5% (on average for four registers - 10.3%). A higher risk of death (1.5-2.7 times ..." | ||
| Vol 12, No 3 (2016) | CLINICAL AND LABORATORY CHARACTERISTICS OF PATIENTS WITH ISCHEMIC HEART DISEASE RESISTANT TO ACETYLSALICYLIC ACID IN PERIOPERATIVE PERIOD OF CORONARY ARTERY BYPASS GRAFT: RESULTS OF AN OPEN PROSPECTIVE STUDY | Abstract PDF (Eng) similar documents |
| Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein, A. V. Kovalev, V. G. Sukhovol'skiy, A. A. Savchenko | ||
| "... of enteric forms of ASA. “Transient” ASA-resistance was detected in 12.5% of ASA-resistant patients on the 1 ..." | ||
| Vol 13, No 1 (2017) | VARIABILITY IN LEVELS OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA DEPENDING ON AGE AND SEX AND ITS IMPORTANCE IN THE DIAGNOSIS OF THIS DISEASE | Abstract similar documents |
| V. А. Korneva, T. Yu. Kuznetsova, G. P. Tihova | ||
| "... . Patients older than 70 years with a definite FHC an upper level of LDLC was higher and reached 12.5 mmol/l ..." | ||
| Vol 13, No 3 (2017) | ARTERIAL STIFFNESS AND CARDIOVASCULAR RISK FACTORS IN YOUNG MEN (41-44 YEARS) | Abstract PDF (Eng) similar documents |
| O. Yu. Isaykina, V. B. Rozanov, E. Yu. Zvolinskaya, H. S. Pugoeva, A. A. Alexandrov | ||
| "... with the augmentation index (r=0.131) and augmentation BP (r=0.125) was obtained, but no correlation between IMT ..." | ||
| Vol 13, No 4 (2017) | OCCURRENCE OF THE METABOLIC SYNDROME AND ITS EFFECT ON CARDIOVASCULAR RISK IN PATIENTS WITH GOUT | Abstract similar documents |
| I. I. Polskaya, I. M. Marusenko, T. I. Kulagina, N. N. Vezikova | ||
| "... (aged 55.3±12.5 years; men 73.3%) with MS without gout and other inflammatory diseases. The following ..." | ||
| Vol 13, No 5 (2017) | INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION | Abstract similar documents |
| E. V. Tavlueva, A. V. Alekseenko, O. V. Gruzdeva, O. L. Barbarash | ||
| "... of acetylsalicylic acid (100 mg/day) and ticagrelor 90 mg twice a day. ADP-induced platelet aggregation (1.25 and 2 ..." | ||
| Vol 13, No 5 (2017) | THE ROLE OF FACTORS AFFECTING THE FORMATION OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION | Abstract similar documents |
| M. V. Kurkina, A. G. Avtandilov, I. A. Krutovcev | ||
| "... – 125.9±27.4 g/m2, in the third group – 121.5±15.6 g/m2 and in the fourth one – 126.1±11.5 g/m2 ..." | ||
| Vol 7, No 5 (2011) | AMLODIPINE IN CORRECTION OF HIGH RISK ARTERIAL HYPERTENSION: FOCUS ON MECHANISMS OF INFLAMMATION | Abstract similar documents |
| A. A. Tarasov, S. I. Davydov, T. A. Bezborodova, M. A. Gordeeva, A. R. Babaeva | ||
| "... .3 to 1.25 min in the main group. Significant reduction of IL-6 blood level from 16.6 (5.0; 22.5) to 6 ..." | ||
| Vol 2, No 1 (2006) | ANTIHYPERTENSIVE TREATMENT WITH COMBINED DRUG OF LOSARTAN AND HYDROCHLOROTHIAZIDE | Abstract similar documents |
| R. M. Linchak, K. M. Shumilova, A. D. Martinyuk, T. A. Gusaim, E. V. Semyonova, L. G. Zhirova, S. A. Boitsov | ||
| "... losartan, 12,5 mg hydrochlorothiazide) in patients with arterial hypertension (AH) of I-III grade with high ..." | ||
| Vol 10, No 2 (2014) | CLINICAL AND MORPHOLOGICAL APPROACH TO DIAGNOSIS OF "IDIOPATHIC" ARRHYTHMIAS AND DILATED CARDIOMYOPATHY SYNDROME AS A BASIS FOR DIFFERENTIATED THERAPY. Part II (Treatment) | Abstract similar documents |
| O. V. Blagova, A. V. Nedostup, E. A. Kogan, V. A. Sulimov, Yu. V. Osipova, V. P. Sedov, A. G. Kupriyanova, V. A. Zaydenov, A. E. Donnikov, V. V. Kadochnikova | ||
| "... women, age 46.9±12.5 years) were included in the main group. 51 people (patients with ischemic heart ..." | ||
| Vol 9, No 3 (2013) | ANTIHYPERTENSIVE EFFICACY AND INFLUENCE ON SEXUAL FUNCTION OF VALSARTAN AND VALSARTAN AND HYDROCHLOROTHIAZIDE COMBINATION IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| V. I. Podzolkov, A. V. Vigdorchik | ||
| "... OD. A combination of the valsartan with hydrochlorothiazide (12.5–25 mg/d), amlodipine (5–10 mg/d ..." | ||
| Vol 11, No 3 (2015) | THE EFFECT OF NEBIVOLOL ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH MILD HYPERTENSION | Abstract similar documents |
| I. L. Tepoyan, D. V. Nebieridze, I. A. Skripnikova, A. S. Safaryan, V. A. Vygodin, V. E. Novikov, L. M. Murashko | ||
| "... with nebivolol (5-7.5 mg/day) and patients of the control group received treatment with atenolol (12.5-25 mg/day ..." | ||
| Vol 9, No 5 (2013) | ASSESSING FACTORS THAT FORM PATIENT’S ATTITUDE TO TREATMENT PRECEDING HOSPITALIZATION FOR ACUTE CORONARY SYNDROM (DATA OF QUESTIONNAIRE WITHIN THE LIS REGISTER) | Abstract PDF (Eng) similar documents |
| Yu. V. Lukina, M. L. Gynzburg, V. P. Smirnov, S. Yu. Martsevich, N. P. Kutishenko, A. V. Fokina, E. V. Daniels | ||
| "... patients adhered to doctors’ recommendations better. According to the patients (125 patients – 46 ..." | ||
| Vol 1, No 3 (2005) | COMPARATIVE ASSESSMENT OF EFFECT OF COMBINED DRUGS OF ACE INHIBITOR AND DIURETIC (“NOLIPREL FORTE” AND “CAPOZIDE”) ON CARDIOVASCULAR REMODELING IN HYPERTENSIVE PATIENTS | Abstract similar documents |
| T. D. Kaplanov, V. V. Ivanenko, N. V. Ryasancevа, A. V. Legkiy, L. P. Anisimova, Yu. M. Lopatin | ||
| "... of combined drug of ACE inhibitors and diuretic. 25 patients took NF (perindopril 4 mg and indapamide 1,25 mg ..." | ||
| Vol 1, No 3 (2005) | COMPARATIVE STUDY OF COMBINED DRUGS OF ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE: «RENIPRIL HT» AND «CO-RENITEC» IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION | Abstract similar documents |
| S. Y. Martsevich, J. V. Lukina, A. D. Deev, N. S. Oganisyan, N. A. Dmitrieva, N. Y. Ivanenkova, A. A. Serazhim, V. P. Voronina, M. P. Kozireva | ||
| "... every 2 weeks within the whole period of study. Within first 2 weeks patients were treated with RH 10/12,5 ..." | ||
| Vol 3, No 3 (2007) | COMPARATIVE EVALUATION OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE | Abstract similar documents |
| S. N. Tolpygina, E. V. Shilova, S. Y. Martsevich | ||
| "... (HCT) 12.5-25 mg per day was added. There was another 2-week wash-out period between two active ..." | ||
| Vol 8, No 5 (2012) | HIGH HEART RATE AS A POTENTIAL RISK FACTOR FOR DEVELOPMENT OF CARDIOVASCULAR DISEASES IN WOMEN WITH RHEUMATOID ARTHRITIS | Abstract similar documents |
| D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov | ||
| "... examined. The control group consisted of 125 women without rheumatic diseases. Aside from clinical symptoms ..." | ||
| Vol 8, No 5 (2012) | EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN ACHIEVEMENT OF TARGET BLOOD PRESSURE IN DIABETIC PATIENTS | Abstract similar documents |
| O. A. Koshel'skaya, O. A. Zhuravleva, R. S. Karpov | ||
| "... .0±8.3 to 125.0±7.6/76.8±4.9 mm Hg (p<0.05) and average daily BP (ABPM) decreased to 120.1±10.0/71.7±6 ..." | ||
| Vol 14, No 2 (2018) | HYPERTENSION AND DIABETES MELLITUS TYPE 2 | Abstract similar documents |
| M. E. Statsenko, M. V. Derevyanchenko | ||
| "... in the level of office systolic (SBP) and diastolic blood pressure (DBP) by 22.3 and 12.5%, respectively, heart ..." | ||
| Vol 16, No 5 (2020) | The Role of Adherence to Basic Pharmacotherapy of Heart Failure for Prevention of Late Adverse Events in Patients with Coronary Artery Disease and Left Ventricular Dysfunction After Surgical Revascularization of Myocardium | Abstract PDF (Eng) similar documents |
| O. A. Yepanchintseva, K. A. Mikhaliev, I. V. Shklianka, O. J. Zharinov, B. M. Todurov | ||
| "... follow-up. Material and methods. A prospective non-controlled single-center study included 125 ..." | ||
| Vol 16, No 5 (2020) | Treatment of Patients with Acute Coronary Syndrome with ST Segment Elevation in Clinical Practice of the Republic of Karelia: the Results of 10-year Register | Abstract similar documents |
| I. S. Skopets, N. N. Vezikova, A. V. Malafeev, A. N. Malygin, V. A. Litvinova | ||
| "... .7% of patients had a low (49-125 points), 33.7% an average (126-154 points), and 40.6% of patients had a high ..." | ||
| Vol 16, No 6 (2020) | Monitoring Cardiovascular Medicine Prices as a Tool for Analyzing the Effectiveness of Government Intervetions to Ensure Access to Medicines at the Regional Level | Abstract similar documents |
| C. M. Razzakova, L. E. Ziganshina | ||
| "... , with the decrease in MPR from 2.22 [1.12-3.91] to 1.25 [0.44-2.32], (p<0.05). In the public sector ..." | ||
| Vol 17, No 2 (2021) | Main Factors Related with the White Coat Effect Level in Patients with Arterial Hypertension and Bronchial Asthma | Abstract similar documents |
| G. F. Andreeva, M. I. Smirnova, V. M. Gorbunov, A. S. Kurekhyan, Y. N. Koshelyaevskaya | ||
| "... was performed and, if necessary, the drug dose was corrected. Results. The study included 125 patients, 28 men ..." | ||
| Vol 4, No 1 (2008) | EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN AND ITS COMBINATION WITH DIURETICS ON MYOCARDIAL MORPHO-FUNCTIONAL CONDITIONS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY | Abstract similar documents |
| S. N. Tolpygina, E. V. Oschepkova, L. M. Sergakova, A. N. Rogoza | ||
| "... response to losartan monotherapy (50-100mg/day) hydrochlorothiazide (12,5mg) was added to losartan (50mg) 4 ..." | ||
| Vol 15, No 2 (2019) | Current Predictors of Atrial Fibrillation Progression | Abstract PDF (Eng) similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... ventricular (LV) hypertrophy (odds ratio [OR] 1.25; 95% confidence interval [95%CI] 1.03-1.52) and increased ..." | ||
| Vol 20, No 5 (2024) | Association between renin-angiotensin system gene polymorphism and cardio-ankle vascular index in patients with COVID-19 | Abstract similar documents |
| V. I. Podzolkov, A. E. Bragina, E. S. Ogibenina, I. I. Shvedov, A. R. Komelkova | ||
| "... .e., A/A+A/C versus C/C, was found in subjects with normal CAVI: 95.0% and 5.0% compared with 87.5% and 12.5 ..." | ||
| Vol 18, No 4 (2022) | Safety and Tolerability of Implanted Subcutaneous Cardioverter-Defibrillator Systems | Abstract similar documents |
| A. V. Vereshchagina, T. M. Uskach, O. V. Sapelnikov, V. A. Amanatova, I. R. Grishin, A. A. Kulikov, V. S. Kostin, R. S. Akchurin | ||
| "... , конечного систолического объема - 144 (125;182) мл, продолжительности QRS - 100 (94;108) мсек. По данным ..." | ||
| Vol 17, No 4 (2021) | E-cigarette Smoking (Vaping) and Markers of Vascular Wall Damage in Young Subjects without Cardiovascular Disease | Abstract PDF (Eng) similar documents |
| V. I. Podzolkov, A. E. Bragina, N. A. Druzhinina, L. N. Mohammadi | ||
| "... .79; 0.93]) when compared with nonsmokers (1.125 [1.01; 1.18]), and the median ABI in vapers was lower ..." | ||
| Vol 19, No 1 (2023) | Incidence and Severity of Acute Myocardial Injury after Thoracic Surgery: Effects of Nicorandil | Abstract similar documents |
| K. V. Protasov, O. A. Barahtenko, E. V. Batunova, E. A. Rasputina | ||
| "... rates of hs-cTnI [14.8 (0.7;42.2) vs 32.5 (14.0;125.0) ng/l; p<0.01) and sST2 [24.4 (10.3;42.4) vs 47 ..." | ||
| Vol 7, No 1 (2011) | ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION | Abstract similar documents |
| R. D. Kurbanov, N. U. Zakirov, Sh. K. Azizov | ||
| "... ) was 12,5%. The maximum rate of sinus rhythm recovery was observed during the first 2-3 days ..." | ||
| Vol 15, No 6 (2019) | Seasonal Indicators of Blood Pressure, Data of Asthma Control Questionnaires and Quality of Life in Hypertensive Patients with Bronchial Asthma | Abstract similar documents |
| G. F. Andreeva, M. I. Smirnova, V. M. Gorbunov, A. S. Kurekhyan, Ya. N. Koshelyaevskaya | ||
| "... . Results. Hypertensive patients with/without bronchial asthma (n=125; 28 men, 97 women, average age 62.6Ѓ}8 ..." | ||
| Vol 16, No 1 (2020) | Chronic Heart Failure in Early Rheumatoid Arthritis Patients Prior to Basic Antirheumatic Therapy | Abstract PDF (Eng) similar documents |
| I. G. Kirillova, D. S. Novikova, T. V. Popkova, H. V. Udachkina, E. I. Markelova, Yu. N. Gorbunova, Yu. O. Korsakova, S. N. Gluchova | ||
| "... for NT-proBNP was less than 125 pg/ml. Results. CHF was diagnosed in 24 (33%) patients: in 23 patients ..." | ||
| Vol 16, No 5 (2020) | Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis) | Abstract similar documents |
| O. V. Reshetko, A. V. Sokolov, N. V. Furman, V. V. Agapov | ||
| "... prescription was noted. In 2016-2017 OACs were prescribed only in 12.5% of patients at all stages ..." | ||
| Vol 15, No 2 (2019) | Long-Term Outcomes of Pharmacoinvasive Reperfusion Strategy Depending on the Choice of Thrombolytic Agent in ST-Segment Elevation Myocardial Infarction | Abstract similar documents |
| A. V. Khripun, A. A. Kastanayan, M. V. Malevannyi, Y. V. Kulikovskikh | ||
| "... (49.8±7.4% vs 47,4±6.8%; p=0.048), lower index of impaired local contractility (1.19 [1.06; 1.38] vs 1.25 ..." | ||
| Vol 15, No 4 (2019) | Syndrome of Primary Myocardial Hypertrophy: Clinical and Morphological, Genetic Diagnostics and Comparison of Sarcomerial Variants of Cardiomyopathy and its Phenocopy | Abstract similar documents |
| O. V. Blagova, E. V. Zaklyazminskaya, E. A. Kogan, V. P. Sedov, G. М. Radzhabova, M. Е. Polyak, A. V. Nedostup | ||
| "... of ejection fraction (EF) (55.7±12.5% vs 62.5±10.1% in HCM, p=0.08). The morphologic signs of myocarditis were ..." | ||
| Vol 15, No 5 (2019) | Patients with History of Myocardial Infarction and Acute Cerebrovascular Accidentin Clinical Practice: Demographic, Clinical Characteristics, Drug Treatment and Outcomes (Data of Outpatient and Hospital Registry REGION) | Abstract similar documents |
| E. Yu. Okshina, M. M. Loukianov, S. Yu. Martsevich, S. S. Yakushin, N. P. Kutishenko, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, E. V. Kudryashov, S. A. Boytsov, O. M. Drapkina | ||
| "... and methods. The total 1886 patients with a history of ACVA (aged of 70.6±12.5 years, 41.9% men) were enrolled ..." | ||
| Vol 18, No 1 (2022) | Noncompact Myocardium with Dilated Phenotype: Manifestations, Treatment and Outcomes in Comparison with Other Forms of Dilated Cardiomyopathy Syndrome | Abstract PDF (Eng) similar documents |
| O. V. Blagova, E. V. Pavlenko, N. V. Varionchik, V. P. Sedov, N. V. Gagarina, E. A. Mershina, M. E. Polyak, E. V. Zaklyazminskaya, A. V. Nedostup | ||
| "... on prognosis in comparison with other forms of DCM syndrome. Methods. The NCM registry includes 125 patients ..." | ||
| Vol 18, No 2 (2022) | Sequelae of COVID-19 at long-term follow-up after hospitalization | Abstract PDF (Eng) similar documents |
| N. V. Pogosova, F. N. Paleev, A. K. Ausheva, D. T. Kuchiev, S. A. Gaman, T. N. Veselova, M. B. Belkind, O. Yu. Sokolova, R. A. Zhetisheva, S. K. Ternovoy, S. A. Boytsov | ||
| "... cardiovascular diseases (CVD). A total of 213 patients aged 19 to 94 years old (mean age 56.8±12.5, median 57 ..." | ||
| Vol 19, No 4 (2023) | Predictors of recurrent cardiovascular events in patients with a single-vessel coronary artery disease after ST-segment elevation myocardial infarction | Abstract similar documents |
| V. E. Oleynikov, E. V. Averyanova, A. A. Tonkoglaz, M. V. Lukyanova | ||
| "... : “RE” group — 26 patients (17.2%) with registered recurrent cardiac events, and “ST” group — 125 ..." | ||
| Vol 20, No 6 (2024) | The impact of clinical decision support systems on adherence to clinical guidelines and achieving target levels of low-density lipoprotein cholesterol in patients at risk of developing cardiovascular events (SuccESS) | Abstract similar documents |
| K. S. Astrakova (Benimetskaya), I. L. Mikheenko, A. E. Uranov, A. A. Gartung, E. A. Kovalev, A. A. Spiridonov, I. I. Shestova, I. L. Strokolskaya, M. A. Meshkova, L. I. Esev, А. V. Reznik, V. А. Petrakovskaia, A. M. Shangina, Yu. E. Efremova, I. V. Sergienko, M. V. Ezhov, O. L. Barbarash, P. N. Paleev | ||
| "... -intensity statin therapy decreased from 12.5% to 9% (-27%, p<0.001) in the main cohort and from 47.4% to 40 ..." | ||
| 1 - 91 of 91 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
